For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor ...

Glenmark Pharmaceuticals on Tuesday said its US arm has launched anticoagulant Phytonadione injectable emulsion.   Glenmark Pharmaceuticals Inc., USA has launched Phytonadione injectable emulsion of ...

Oral anticoagulants that require no monitoring ... provides greater simplicity and a welcome alternative to the daily injections that are required for low-molecular-weight heparins, the most ...

Are you searching for effective medications to treat 'Anticoagulants'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for ...

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...

May potentiate cyclosporine. May antagonize anticoagulants (monitor), isoniazid, other CYP3A4 substrates (eg, indinavir, erythromycin). Increased risk of arrhythmias with digitalis. May need to ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, ...

Atrial fibrillation (AF) is a common heart condition that affects about one in three people at some point in their lives. It ...

Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and ...

Emergency and hospital medicine physicians often chose anticoagulants for acute pulmonary embolism (PE) based on institutional culture and past practices rather than clinical guidelines.